Difference between revisions of "Example orders for Panitumumab (Vectibix) in colon cancer"
Jump to navigation
Jump to search
m (Text replace - "'''Use of this site is subject to you reading and agreeing with the terms set forth in the disclaimer.''' {{TOC limit|limit=3}}" to "'''Use of this site is subject to you read) |
Warner-admin (talk | contribs) m (Text replacement - " " to " ") |
||
| (10 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
| − | '''Use of this site is subject to you reading and agreeing with the terms set forth in the [[HemOnc.org_-_A_Hematology_Oncology_Wiki:General_disclaimer|disclaimer]].''' | + | <!--'''Use of this site is subject to you reading and agreeing with the terms set forth in the [[HemOnc.org_-_A_Hematology_Oncology_Wiki:General_disclaimer|disclaimer]]. If this is your first time visiting, we suggest you read the [[tutorial]].'''--> |
Remember that example order sets that may contain additional information about supportive medications, suggestions for monitoring, hydration, and pre-treatment screening information for chemotherapy regimens are purely anecdotal, provided only as examples of what some other providers may be using, and are typically not based on references in the primary literature. | Remember that example order sets that may contain additional information about supportive medications, suggestions for monitoring, hydration, and pre-treatment screening information for chemotherapy regimens are purely anecdotal, provided only as examples of what some other providers may be using, and are typically not based on references in the primary literature. | ||
| Line 7: | Line 7: | ||
==Panitumumab (Vectibix)== | ==Panitumumab (Vectibix)== | ||
| − | Original references may be found at [[Colon_cancer# | + | Original references may be found at [[Colon_cancer#Panitumumab_monotherapy|Panitumumab (Vectibix)]] |
===Example regimen #1=== | ===Example regimen #1=== | ||
| Line 16: | Line 16: | ||
Hydration: | Hydration: | ||
| − | *500 ml NS at KVO rate as running IV for chemotherapy infusion. | + | *500 ml NS at KVO rate as running IV for chemotherapy infusion. Give up to 500 ml NS. |
Monitoring: | Monitoring: | ||
| − | *Hold if ANC | + | *Hold if ANC less than 1000 or platelets less than 100 and notify physician. |
*Check magnesium prior to each dose of panitumumab | *Check magnesium prior to each dose of panitumumab | ||
[[Category:Example chemotherapy order sets]] | [[Category:Example chemotherapy order sets]] | ||
Latest revision as of 01:53, 1 June 2023
Remember that example order sets that may contain additional information about supportive medications, suggestions for monitoring, hydration, and pre-treatment screening information for chemotherapy regimens are purely anecdotal, provided only as examples of what some other providers may be using, and are typically not based on references in the primary literature.
Panitumumab (Vectibix)
Original references may be found at Panitumumab (Vectibix)
Example regimen #1
- Panitumumab (Vectibix) 6 mg/kg IV over 60 minutes on day 1
- Use 0.22 micron non-DEHP/paclitaxel tubing.
14-day cycles
Hydration:
- 500 ml NS at KVO rate as running IV for chemotherapy infusion. Give up to 500 ml NS.
Monitoring:
- Hold if ANC less than 1000 or platelets less than 100 and notify physician.
- Check magnesium prior to each dose of panitumumab